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OBJECTIVES This article describes a catheter system designed to create linear atrial lesions and
identifies electrophysiologic markers that are associated with the creation of linear
lesions.
BACKGROUND Atrial fibrillation (Afib) is the most common arrhythmia in humans and causes a significant
morbidity. The success of surgical interventions has provided the impetus for the develop-
ment of a catheter-based approach for the ablation of Afib.
METHODS We tested a catheter system with 24 4-mm ring electrodes that can create loops in the atria.
The electrodes can be used to record electrical activity and deliver radiofrequency power for
ablation. In 33 dogs, 82 linear lesions were generated using three power titration protocols:
fixed levels, manual titration guided by local electrogram activity and temperature control.
Bipolar activity was recorded from the 24 electrodes before, during and after lesion
generation. Data were gathered regarding lesion contiguity, transmurality and dimensions;
the changes in local electrical activity amplitude; the incidence rate of rapid impedance rises
and desiccation or char formation; and rhythm outcomes.
RESULTS Catheter deployment usually requires ,60 s. Linear lesions (12 to 16 cm in length and 6 6
2 mm wide) can be generated in 24 to 48 min without moving the catheter. Effective lesion
formation can be predicted by a decrease of greater than 50% in the amplitude of bipolar
recordings. Splitting or fragmentation of the electrogram and increasing pacing threshold
(3.1 6 3.3 mV to 7.1 6 3.8 mV, p , 0.01) are indicative of effective lesion formation.
Impedance rises and char formation occurred at 91 6 12°C. Linear lesion creation does not
result in the initiation of Afib. However, atrial flutter was recorded after the completion of the
final lesion in 3/12 hearts. When using temperature control, no char was noted in the left
atrium, whereas 8% of the right atrium burns had char.
CONCLUSIONS This adjustable loop catheter forces the atrial tissue to conform around the catheter and is
capable of producing linear, contiguous lesions up to 16 cm long with minimal effort and
radiation exposure. Pacing thresholds and electrogram amplitude and character are markers of
effective lesion formation. Although Afib could not be induced after lesion set completion,
sustained atrial flutter could be induced in 25% of the hearts. (J Am Coll Cardiol 1999;33:
972–84) © 1999 by the American College of Cardiology
Currently, the Maze operation is considered to be the most
effective treatment of chronic atrial fibrillation (Afib) with
the highest long-term success rate, over 90% in selected
series (1,2). In recent years we have witnessed the expanding
use of transcatheter ablation to replace surgical therapy for
arrhythmias. A percutaneous transvascular catheter ap-
proach to ablate Afib by separating atrial tissue with linear
RF lesions, if effective even in a select patient population,
would be a significant achievement in the treatment of this
highly prevalent disorder.
The goal of catheter-based ablation of Afib should be safe
minimal tissue destruction allowing for the restoration of
sinus rhythm under autonomic nervous system control com-
bined with recovery of atrial mechanical transport to prevent
the development of a thromboembolic event and provide
hemodynamic benefits for the patient. The atrial chambers are
globular, elastic and only a few millimeters thick. Therefore,
we hypothesized that a catheter system that creates adjustable
loops in dynamic contact with the atrial walls is most likely to
be able to adapt to the atrial structure and create good contact
for ablating and recording. This article summarizes our expe-
rience using a catheter technology that was designed to create
linear contiguous lesions in both atria.
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METHODS
The Afib ablation system. The catheters were constructed
by EPT/Boston Scientific Corporation and consist of three
parts:
1. Catheter: Two versions of a catheter with 24 ablating/
recording ring electrodes were used (Fig. 1). One version
has a monorail ring at its distal tip through which a
guidewire is threaded (11 procedures) (3). A second
generation has a guidewire permanently attached to its
distal tip (22 procedures). We have tested the system
with and without 24 thermocouple temperature sensors
placed under the center of each of the ring electrodes
along the outer surface of deflection.
2. Guidewire: A long, soft guidewire enables deflection of
the distal tip of the catheter. The first version threads
through the monorail and has a ball and a soft floppy
pigtail on its end; the second catheter’s guidewire is
permanently attached to the distal tip.
3. Sheaths: The system uses a variety of 70-cm 11-F guiding
sheaths with various angular bends at the distal end.
Each sheath is equipped with a central port, a locking
hemostatic seal mechanism and a side-arm infusion port.
Depending on the magnitude of the guidewire retraction
and the size of the catheter portion extending from the
sheath, the electrode portion of the catheter can form loops
of various sizes. The body of the catheter applies pressure on
the thin atrial walls and forces them to stretch around the
catheter, maintaining consistent electrode–tissue contact
along the entire length of the ablation portion of the
catheter. Because the forces that are applied to the atrial
walls are distributed along the catheter shaft around the
loop, it is presumed that no single point is exposed to
excessive forces. The locking mechanism holds the catheter
and guidewire firmly in position.
Experimental testing of the Afib ablation catheter. All
procedures were performed in compliance with the Amer-
ican Heart Association’s guidelines for animal research and
were approved by the University of Illinois at Chicago’s
Animal Care Committee. Dogs (25 to 35 kg) were premed-
icated with Nembutal (0.5 cc/kg) and transported to the
laboratory, where anesthesia was maintained with halothane
(1 to 1.5%) and O2 (2 liter/min). The femoral vein was
cannulated with a self-sealed 14-F short access sheath. A
precurved 70-cm 11-F guiding sheath was inserted via the
access sheath into the right atrium (RA) or the left atrium
(LA). For LA placement, transseptal cannulation was
achieved via the Brockenbrough technique using a specially
designed dilator and a long transseptal needle under trans-
esophageal echocardiographic (TEE) guidance. In addition,
the jugular and femoral veins were cannulated and 6-F
quadripolar catheters were placed in the coronary sinus and
the high RA. After the procedures, the hearts were excised
and examined for evidence of perforation of or damage to
the valves, main vessels, nerve trunks around the heart and
chamber walls.
Catheter positioning. Predetermined anatomical targets
were chosen on the basis of the surgical Maze lesion
locations, the mobility of the catheter and the ability of the
catheter to adapt to the right and left atria. Various
combinations of the following linear lesions were generated:
● RA Loop: A circular lesion from the anterior septal
tricuspid valve (TV) to the right atrial appendage (RAA)
to the superior vena cava and back to the inferior vena
cava (IVC).
● RAI: A RA isthmus lesion where the catheter is looped
into the right ventricle with the ablation electrodes across
the TV ring extending into the IVC.
● LAH: A circular horizontal lesion placed under the
pulmonary veins (PVs) in the mid-LA, above the mitral
valve (MV), as indicated by a coronary sinus catheter and
Abbreviations and Acronyms
Afib 5 atrial fibrillation
ANOVA 5 analysis of variance
IVC 5 inferior vena cava
LA 5 left atrium/atrial
LAH 5 left atrial horizontal lesion
LAV 5 left atrial vertical lesion
LEA 5 local electrical activity
MV 5 mitral valve
PV 5 pulmonary vein
RA 5 right atrium/atrial
RAA 5 right atrial appendage
RAI 5 right atrial isthmus lesion
RF 5 radiofrequency
TEE 5 transesophageal echocardiography
TV 5 tricuspid valve
Figure 1. The two versions of the adjustable loop catheter. The
fixed-tip (A, B) and monorail (C, D) systems are shown. The size
of the loop can be adjusted by retracting the catheter into or
pushing it further out of the guiding sheath.
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the atrial and ventricular electrograms recorded from each
of the 24 electrodes on the catheter.
● LAV1: A vertical lesion extending from the MV annulus
medial of the PVs.
● LAV2: A vertical lesion extending from the MV to the
LA appendage, lateral of the PVs.
Figure 2 depicts representative fluoroscopic images of the
catheter positions for each lesion. An important factor in
catheter positioning is the ability to reproduce placement in
specific anatomic locations in different hearts. When de-
flected, the catheter tends to settle in the position with the
largest circumference. However, by positioning the sheath
at different levels, a variety of positions can be achieved in
both the right and left atria.
In five dogs, the time required to place the catheter (with
the guidewire fixed to the tip) in the RA Loop and the
LAH position was documented. The time was measured
from insertion of the catheter into the sheath until the
catheter was firmly placed in the predefined location. In
addition, the time needed to retract the catheter back into
the sheath was recorded, and the total duration of fluoro-
scopic exposure was measured. A total of 34 catheter
placements were timed. Continuous fluoroscopic images
were recorded for each positioning effort, and successive
attempts at positioning were compared to verify proper
positioning. Electrical activity was recorded and was used to
verify correct anatomical placement with respect to the
atrioventricular ring. After the final placement, lesions were
generated in each of the hearts. The hearts were excised, and
the lesions were used to verify the anatomic positioning.
Lesion formation. In the 33 dogs, a total of 82 linear
lesions were generated in the RA (44 lesions) and LA (38
lesions). Radiofrequency (RF) power was delivered sequen-
tially via each electrode using three protocols including:
● Power (21 dogs, 61 linear lesions, Radionics generator):
Delivering power for 40 s at each of two power levels (5
then 10 W or 10 then 20 W) for a total of 80 s.
● Amplitude (eight dogs, 13 linear lesions, Radionics or EPT
generator): Titrating power from 0 to 50 W for 120 s
based on online changes in local electrical activity record-
ings.
● Temperature (five dogs, eight linear lesions, EPT generator):
Titrating power from 0 to 50 W for 60 s to maintain a
measurement of 70°C from the thermocouple on the
ablating electrode.
Therefore, the maximum overall dwell times for ablating
via all 24 electrodes were 24, 32 and 48 min for the
temperature, power and amplitude protocols, respectively.
In some cases the dwell times during ablation were less, if
the atrium was small and required ablation with less than 24
electrodes to complete a linear lesion. One dog received
lesions using two different power protocols (amplitude and
temperature). Bipolar recordings from the 24 electrodes
were obtained from overlapping electrode pairs (1–2,
2–3 . . . 22–23, 23–24) before, during and after lesion gen-
eration. In 31 ablation procedures (80 lesions), the incidence
of rapid impedance rises to .200 V was documented.
In six dogs, nine linear lesions were created, and the
maximum power and maximum temperature were recorded.
The amplitude of the atrial electrical activity was measured
before and after lesion generation at each of the bipolar
electrodes at fixed amplification and filtering (30 to
500 Hz), and the percent decrease was calculated. After
excision, the hearts were soaked in tetrazolium blue stain for
8 h. The width and length of each individual lesion and the
total linear lesion length were measured. The quality of each
of the individual lesions with respect to contiguity, trans-
murality and desiccation or char formation was assessed.
The lesions were defined as transmural and contiguous if no
surviving muscle could be seen between the lesions and clear
contiguous lesions could be seen on the epicardial surface.
Char was defined as loosely adherent material that can be
easily dislodged from its underlying tissue; desiccation was
defined as tightly adherent, shallow, discolored material that
is firmly attached to the underlying tissue. For 11 lesions
created in eight dogs with amplitude or temperature power
delivery protocols, each individual lesion was categorized as
Figure 2. Fluoroscopic views of the catheter within the atria. The
five locations where linear lesions were created are shown. Each
lesion’s relationship to cardiac anatomic landmarks is described in
the text. LAH 5 left atrial horizontal lesion; LAV 5 left atrial
vertical lesion; RA 5 right atrial; RAI 5 RA isthmus lesion.
974 Avitall et al. JACC Vol. 33, No. 4, 1999
Linear Lesion Creation March 15, 1999:972–84
follows: type 0—no identifiable lesion despite power appli-
cation; type 1—minor superficial lesion formation that is
neither contiguous nor transmural; type 2—lesion that is
either contiguous or transmural; type 3—lesion that is both
contiguous and transmural (the ideal lesion type); type
4—lesion that is contiguous and transmural but has adher-
ent desiccation, and type 5—lesion that is contiguous,
transmural and covered with loosely attached char.
In seven dogs, the average heart rate and P-R interval was
calculated before and after generating a set of linear lesions.
In three dogs (152 individual burns), bipolar pacing
threshold values were obtained by pacing (pulse width 5
2 ms, cycle length 5 300 ms) between two adjacent
electrodes before and after applying RF power to the
cathodal electrode, without moving the catheter.
Rhythm outcomes. In 12 dogs, 50-ms cycle length burst
pacing was applied for 5 s to the RAA before and after the
completion of 31 linear lesions, and the resulting rhythm
was recorded. The rhythm was categorized as sinus, Afib or
atrial flutter. Its duration was defined as sustained (lasting
.180 s) or nonsustained (lasting 30 to 180 s).
Epicardial mapping. To examine the effects of lesions on
local electrical activity, the RA and LA were mapped before
and after the creation of RA and LA lesions. The chest and
pericardium were opened via a median sternotomy, and a
handheld high density mapping plaque (112 bipolar elec-
trodes) was placed on the LA and RA surfaces. Activation
of the RA and LA was recorded during 400-ms pacing from
the RA and LA appendages. The plaque was removed, and
the chest was clamped closed. Lesions were created with the
catheter from the endocardial surface across the areas where
the plaque had been placed on the RA and LA. The chest
was reopened, the plaques were repositioned in the same
areas as before ablation and electrical activity was recorded
during 400-ms pacing from the RA and LA appendages.
Statistical analysis. Summary data are expressed as raw
mean value 6 SD. Since the focus of this report is on the
methodology for the creation of contiguous transmural
linear lesions, we analyzed the effects of different power
titration techniques by assessing the local electrical activity
pre and post individual lesion creation and by defining the
temperature needed to create the desired lesions. The
continuous data were analyzed using a nested random effects
analysis of variance (ANOVA) model that treats the dogs as
blocks (random) and the observations from each dog as a
nested subsample. The local electrical activity (LEA) group
and atrium were also included as factors in the ANOVA.
The p values were considered significant if they met the
level of 0.025 since two variables, namely power and
temperature, were simultaneously studied. This adjusted
level ensures, by Bonferroni method, an overall significance
of 0.05. A McNemar’s chi-square test was used to compare
arrhythmia inducibility before and after lesion generation.
RESULTS
Safety. In the 33 dogs, no atrial wall tears occurred due to
the formation of a loop. There were no instances of
perforation of or acute damage to the valves, main vessels or
chamber walls. Transesophageal echocardiography and flu-
oroscopic visualization did not show evidence of pericardial
effusion or tamponade after lesion generation. No acute
mitral or tricuspid regurgitation was recorded using TEE
Doppler evaluation of valvular function. The catheter sys-
tem did not become entrapped in the tricuspid or mitral
valve apparatus. However, if a standard electrophysiologic
catheter was inserted after the deployment of the ablation
catheter, attempts to withdraw the Afib ablation catheter
before the removal of the recording catheter could result in
entrapment of the recording catheter within the loop of the
Afib ablation catheter. To avoid such an event, catheters
inserted into the chamber after deployment of the ablation
catheter should be removed prior to the removal of the
ablation catheter. If entrapment occurs, the ablation cathe-
ter can be pushed back into the chamber, and the other
catheter can be removed. If the Afib ablation catheter is
inserted into the LV across the mitral valve, it can interfere
with proper mitral valve closure and cause mitral regurgita-
tion. We have avoided this interference by using TEE
monitoring of mitral function during the placement of the
catheter in the LA. In seven dogs, the heart rate was 126 6
19 beats per minute before ablation and 118 6 36 after-
wards (p 5 NS), and the P-R interval was 105 6 19 ms
before ablation and 109 6 28 afterwards (p 5 NS). There
was no evidence of third-degree atrioventricular block in any
dogs.
Lesion formation: temperature, local electrogram reduc-
tion. Three protocols were used to manually titrate RF
power. As shown in Table 1, power titration of 5 and 10 W
resulted in 7% impedance rises. Power titration of 10 and
20 W resulted in a 14% incidence of impedance rise. Both
temperature and local electrogram amplitude monitoring
yielded low levels of impedance rises, 5% and 2%, respec-
tively. Lesion character was divided into six categories. The
ideal lesion (type 3) is contiguous and transmural, without
any evidence of desiccation or char on either the tissue or
the catheter. As shown in Figure 3, type 3 lesions were 44%
of the total lesions generated with temperature-based titra-
tion and 46% of the lesions generated with 70% reduction of
local electrogram amplitude. The average recorded temper-
ature for these two protocols was 71 6 7°C for type 3
lesions. If one combines type 3 and 4 lesions, the percent
acceptable lesions increases to 70% and 57% for the tem-
perature and the amplitude protocols, respectively. With
temperature-guided power titration, in multiple cases the
peak temperature exceeded the target temperature leading
to overheating and impedance rises. Impedance rises and
char formation (lesion type 5) were associated with temper-
atures of greater than 91 6 12°C. As shown in Figure 4,
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inadequate lesions (type 0, 1 and 2) were associated with
lower temperatures of 42 6 3°C (p , 0.000, type 0 vs. type
3), 61 6 11°C (p , 0.000, type 1 vs. type 3) and 68 6 4°C
(p 5 NS, type 2 vs. type 3). Overall, the average tempera-
ture was 74 6 13°C and the average local electrogram
reduction was 67 6 34% for the lesions created with
temperature or amplitude guidance.
Table 2 summarizes the data obtained using temperature
control to generate linear lesions in the RA Loop versus
LAH position. The total linear lesion length was 12.4 6
1.3 cm in the RA vs. 16 6 1.1 cm in the LA due to
differences in the circumferential atrial size. Because the
atrial size varied between dogs, the size of the loop needed
to create the encircling lesions did not always require the use
of all of the 24 electrodes. The power requirements in the
LA were significantly lower than in the RA. This is likely
related to variations in the degree of the catheter embedding
into the atrial tissues, especially in the lateral regions of the
LA. In these regions the power levels were often less than
10 W. If an impedance rise occurred, it frequently resulted
in char formation as shown in Figure 5. The high average
initial electrode–tissue impedance provides further evidence
of tissue contact.
Data regarding the decrease in LEA postablation is
summarized in Table 3. When postablation LEA was
minimally decreased, the target temperature often was not
achieved. These data correspond to the lower percentage of
lesions that were transmural and contiguous when LEA
decreased ,50%. This observation contrasts with the
achieved target temperature and high percentage of trans-
Table 1. Impedance Rises During Ablation
Protocol Hearts
Total: RA1LA RA LA
Linear
Lesions Burns
Z
Inc. %
Linear
Lesions Burns
Z
Inc. %
Linear
Lesions Burns
Z
Inc. %
5 & 10 W 6 21 409 27 7 7 148 13 9 14 261 14 5
10 & 20 W 13 38 768 104 14 23 473 66 14 15 295 38 13
Amplitude 8 13 248 5 2 7 130 1 1 6 118 4 3
Temperature 5 8 161 8 5 5 93 6 6 3 68 2 3
Impedance rises with various power titration methods (31 dogs, 80 linear lesions).
Amplitude 5 power titrated until the local electrical activity amplitude decreased by 70%; LA 5 left atrium; RA 5 right atrium; Temperature 5 power titrated to maintain
70°C for 60 s; Z Inc. 5 impedance increase; % 5 percent of individual burns with an impedance rise.
Figure 3. Distribution of individual (4-mm electrode) lesions. Seven linear lesions were created with the 70°C power protocol (white bars),
and four linear lesions were generated with the 70% local electrogram recording reduction protocol (black bars). The majority of lesions
were type 3, which are contiguous and transmural and exhibit no char.
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mural and contiguous lesions associated with a LEA de-
crease between 50% and 100%. These data define the
differences between poor and good tissue contact.
Pacing thresholds. In three dogs, cathodal pacing thresh-
olds were obtained from each electrode (152 total). Average
thresholds as baseline were 3.0 6 3.2 mA and 3.2 6 3.4 mA
in the RA Loop and LAH positions, respectively. Thresh-
olds increased to 6.2 6 3.3 mA and 8.6 6 4.2 mA
postablation representing 205% and 272% increases, respec-
tively, and corresponded to lesion types 3, 4, 5 and 6. The
overall average thresholds before and after ablation for both
atria combined were 3.1 6 3.3 mA and 7.1 6 3.8 mA (p ,
0.01), which is a 388% increase.
Catheter positioning. Table 4 summarizes the time re-
quired to place and remove the catheter and the duration of
radiation exposure in five dogs. Fluoroscopic video record-
ings and electrical recordings were used to verify that the
placements were in the designated positions and were
consistent. In addition, after removal of the hearts, the
location of radiofrequency lesions confirmed the catheter
positioning. Placement of this catheter technology in either
the LAH or RA Loop positions averaged less than 1 min
with minimal radiation exposure.
Recordings, pre-postablation changes and lesion charac-
teristics. Figures 5 to 8 are examples of catheter positions,
LEA recordings and pathological specimens from lesions
created with the loop catheter design. In both the right and
left atria, well defined local electrical recording is shown in
Figure 4. Temperature and individual (4-mm electrode) lesion types. The figure shows the distribution of the average maximum
temperatures for type 0–5 individual lesions. Eleven linear lesions were created in eight dogs using a catheter with a thermistor on each
individual electrode. Seven linear lesions were created with the 70°C power protocol, and four were generated with the 70% local
electrogram recording reduction protocol. Type 3 lesions, which were created with an average temperature of 71 6 7°C, exhibited no
charring or impedance rises. Contiguous and transmural lesions were not formed at lower temperatures (types 0–2). Desiccation (type 4)
and charring (type 5) occurred at higher temperatures.
Table 2. Lesion Generation With Temperature Control
RA Loop
(n 5 4)
LAH
(n 5 2)
Total individual lesions 63 41
Maximum power (W) 21 6 14 11 6 6*
Maximum temperature (°C) 73 6 8 70 6 6
% decrease LEA 65 6 42 66 6 19
% contiguous 98 85
% transmural 97 90
% char 8 0
Width (mm) 6 6 2 6 6 2
Individual lesion length (mm) 6 6 1 6 6 1
Impedance (V) 131 6 20 132 6 12
Total linear lesion length (cm) 12.4 6 1.3 16 6 1.1*
* Designates p # 0.05 vs. circular lesion in the right atrium (RA Loop). Summary of
parameters from six linear lesions generated in four dogs by titrating power from 0 to
50 W to maintain 70°C for 6 s. The statistics are listed as raw mean 6 SD.
LAH 5 horizontal lesion in the left atrium; % decrease LEA 5 percent decrease
in amplitude of local electrical activity after lesion creation.
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Figures 6 and 7. Postablation, the local electrical recording
was markedly decreased and became fractionated or split
into two propagating wave fronts. Furthermore, as shown in
Figure 7 the conduction time of the LA activation from the
septum to the LA appendage was prolonged by 40 ms
because of the encircling lesion above the mitral valve as
shown in the pathological specimen. As shown in the
examples provided in Figures 5, 7 and 8 using this catheter
technology the pulmonary veins encircling lesion can be
achieved with relative ease.
Epicardial maps. Figure 9 shows the distinct changes in
local electrical activity recorded from the high density
mapping plaque. After the creation of linear lesions, the
conduction times across the lesions were markedly delayed,
from 28 ms to 109 ms in the left atrium and from 40 ms to
158 ms in the right atrium, suggesting conduction block
across the lesions.
Rhythm outcomes. Table 5 summarizes the rhythm post–
burst pacing at baseline, after each individual linear lesion
and at the end of the procedure for 12 dogs. In nine of the
12 dogs (75%), the rhythm was sinus with no other
inducible rhythms at the end of the procedure. Sustained
atrial flutter was recorded after 13/31 linear lesions (42%).
After 4/7 (57%) LAH lesions and 4/5 (80%) first LAV
lesions, sustained atrial flutter was inducible. After comple-
tion of all lesions, 3/12 dogs exhibited sustained atrial
flutter. In these three dogs at baseline, one exhibited only
sinus rhythm, one had sustained Afib and one had sustained
atrial flutter. Atrial fibrillation was never a consequence of
creating a linear lesion in any of the 12 dogs.
Atrial flutter. Atrial flutter circuits were both created and
terminated by various linear lesions. In four dogs, the
generation of a linear lesion in the LA resulted in the
inducibility of sustained atrial flutter that was not inducible
preablation. This was a LAH lesion in 2/4 cases and a LAV
lesion in the remaining two dogs. In three of these four
dogs, atrial flutter was noninducible after creating a single
additional linear lesion (one RAI, two LAV), but no
additional lesions were created in the fourth dog. In an
additional dog, sustained atrial flutter was inducible at
baseline, but only sinus rhythm was recorded after generat-
ing a LA linear lesion.
DISCUSSION
Following the work of Cox et al. (1,2), we have assumed
that the ablation of Afib is likely to require lesions that are
linear, contiguous and transmural, and terminate in a
manner that prevents the formation of atrial flutter. How-
Figure 5. Left atrial horizontal (LAH) and vertical (LAV) posi-
tions: gross lesions with charring and corresponding fluoroscopic
images. The tissue specimen illustrates an encircling lesion around
the pulmonary veins (PV) and a vertical lateral lesion connecting
the mitral ring to the encircling lesion. The lesions were generated
with radiofrequency power titration without temperature control.
The heavy char formation is a potential source for embolic stroke.
LAA 5 left atrial appendage; MV 5 mitral valve.
Table 3. Local Electrical Activity
Range of % 2 in
LEA
Average %
2 LEA
Max Power
(W)
Max Temperature
(°C)
% With
Char
%
Cont
%
Trans
% Cont
& Trans
,50 (n 5 40) 5 6 49 17 6 12 65 6 16 3 65 63 60
50 to 100 (n 5 135) 75 6 15 15 6 10 73 6 11 4 90 88 87
The parameters are grouped according to the percentage decrease in the local electrical activity (LEA). These 175 individual lesions were created by using the temperature or
amplitude power delivery protocols to create nine linear lesions in six hearts. The statistics are listed as raw mean 6 SD.
Cont 5 contiguous; Trans 5 transmural.
Table 4. Catheter Placement
Placement
(s)
Removal
(s)
Total Radiation
(s)
RA (n 5 23) 40 6 33 8 6 14 48 6 36
LA (n 5 11) 44 6 18 9 6 3 53 6 17
Time in seconds required to place the catheter in a specific anatomic location, time
needed to remove the catheter and total fluoroscopic imaging duration in five dogs.
n 5 the number of placements.
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Figure 6. Right atrial (RA) loop position: preablation and postablation recordings, gross lesions and fluoroscopic image. Electrode 1 is
located at the inferior vena cava (IVC) atrial junction (note the low amplitude recording at electrode pair 1–2). The recordings from
electrodes 1 to 9 are from the IVC–superior vena cava (SVC) region of the atrium. Electrode pair 9–10 traverses the SVC as depicted by
the low electrogram amplitude. Electrodes 10 to 12 display the earliest electrograms, from the sinus node region at the anterior junction
of the SVC and right atrial appendage (RAA). The recordings 13 to 22 are from across the RAA, and the remaining recordings traverse
the tricuspid ring into the right ventricle. In regions progressively closer to the atrioventricular junction, the amplitude of the ventricular
wave increases. Postablation, the propagation of the right atrial depolarization sequence still initiates from the region recorded by electrodes
9 to 11. However, the creation of the lesion resulted in a marked decrease in the electrograms’ amplitude and fragmentation of the local
recordings. These double potentials coincide with the creation of contiguous linear lesions. TV 5 tricuspid valve.
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Figure 7. Left atrial horizontal position: pre-/postablation recordings, gross lesions and fluoroscopic image. The catheter was placed in a
horizontal position superior to the mitral ring under the pulmonary veins (PV). Note the location of the coronary sinus catheter in relation
to the ablation catheter. The distal and most proximal electrodes, 1 and 24, are both near the transeptal insertion site at the foramen ovale.
The portion of the catheter positioned closer to the mitral ring (electrodes 7 to 13) recorded larger ventricular electrograms. The
depolarization wavefront propagates from the septal region to the most distal recording within the left atrial appendage (LAA) in 50 ms.
After radiofrequency ablation, the local electrogram amplitude decreased significantly. In addition, the recordings from electrodes 8 to 24
became fragmented, and the conduction time from the earliest to the latest electrode increased to 90 ms, 40 ms longer than preablation.
These observations correspond to the linear contiguous lesions in the gross pathological photograph. MV 5 mitral valve.
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ever, current catheter ablation technology is unlikely to
allow the design flexibility capable of creating such lesions
without inflating production costs, compounding complex-
ity and compromising safety. A successful Afib ablation
system might not totally eliminate the arrhythmia, but
instead might increase drug efficacy, decrease the length of
time and the incidence of paroxysmal Afib or convert
sustained Afib to paroxysmal Afib. Since much is yet to be
learned about the mechanism of Afib, a simple safe tech-
nology that provides both mapping and ablation capability
should be used initially.
Safety. Having multiple ablation electrodes on a single
shaft allows for minimal catheter manipulation in creating
long linear lesions and, therefore, may reduce both throm-
boembolic risk and radiation exposure. Once the catheter is
in place, it remains in position for the duration of the power
application to all 24 electrodes. In this study using sequen-
tial power application to each electrode, the total dwell time
during ablation varied between 24 and 48 min depending on
the power protocol utilized.
This ablation system was placed in 33 dogs with no
mechanical injuries to the atrial or ventricular tissues, no
damage to the valvular structures and no entanglement of
the catheter system with tissues. However, if an additional
catheter is introduced into the cardiac chamber after the
deployment of the Afib ablation catheter, this second
catheter should be retracted before the removal of the Afib
catheter. Though it did not occur in any of our procedures,
with this system there is the potential for mechanical injury
to occur across the intra-atrial septum. Once the guiding
sheath is placed across the septum it must be maintained at
this position, particularly during catheter manipulation. If
the sheath is not kept across the atrial septum, expansion of
the catheter loop could result in septal tearing. In addition,
if the catheter is deployed across the mitral ring it may
interfere with valvular closure.
Catheter positioning. Placement of this system in the atria
usually required less than 1 min in this animal model.
Although this system naturally creates loops at the points of
maximal diameter, it can be positioned in various other
anatomic locations by manipulating the guiding sheath. The
catheter naturally adapts to the RA Loop and LAH posi-
tions, whereas the LA vertical positions usually require
sheath manipulation. Poor contact can be improved without
significantly changing the location of the lesion by simply
expanding the size of the loop.
Lesion formation. The most important determinant in the
effective creation of a RF lesion is the electrode–tissue
contact. Using the variable loop concept, the globular-
shaped atrial chambers will adapt around the catheter
providing continuous contact. When using temperature
control with this technology, over 90% of the lesions created
in both atria were both contiguous and transmural; the
incidence of impedance rises was minimized. The catheter
can be used to create linear lesions 6 mm wide and up to
16 cm long with minimal manipulation. In this study, linear
lesions were made by ablating individual electrodes. The
time required to create an entire linear lesion could be
greatly reduced by using a closed-loop system to simulta-
neously deliver RF power to multiple electrodes to maintain
a set temperature.
Recordings. Using 4-mm ring electrodes separated at
4-mm intervals allows for discrete localized recording of
electrical activity before, during and after ablation. Such
recordings provide online monitoring of the lesion forma-
tion. A reduction of greater than 50% in the recorded
electrogram is a good indication of effective lesion forma-
tion. When lesions are created during sinus rhythm or
flutter, the formation of double potentials and fragmented
electrical activity signifies transmural lesion creation. The
Figure 8. Left atrial horizontal position: gross lesions with char-
ring and fluoroscopic image. This linear and contiguous encircling
subpulmonary lesion was created with radiofrequency power titra-
tion of up to 20 W with no temperature control. Char was formed
near the periphery of the electrode–tissue contact areas. The
lesions are bridged with desiccated, blushed tissues between most
of the individual burns. Abbreviations as in Figure 7.
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Figure 9. Epicardial electrical activity maps: before and after linear lesion creation. (A) An isochronal map of the left atrium (LA) during right atrial appendage (RAA) pacing at 400-ms cycle
length. The mapping plaque was placed from the left atrial appendage (LAA) to the mitral valve ring around the atria with the pulmonary veins on the top of the plaque and mitral ring on the
bottom extending to the atrial septum. The atrial activation progressed around the LA from two directions, anteriorly and posteriorly. The total LA activation lasted 28 ms. (B) A map obtained
after creating a LA lesion bisecting the LAA circumferentially and vertically. The LA was activated from the atrial septum and reached the LAA in 109 ms. (C) An isochronal map of the right
atrium (RA), paced from the RAA at 400-ms cycle length. The mapping plaque extended from the RAA (top) and superior vena cava (SVC) (bottom) to the tricuspid ring (top right) and
inferior vena cava (IVC) (right bottom). The atrium was progressively depolarized starting at the RAA and ending at the tricuspid ring with total activation time of 40 ms. (D) An isochronal
map following the RA linear lesion, which bisects across the RAA. The atrial activation started at the RAA and progressed to the lateral wall. The white area represents the territory of recording
electrodes on the plaque where no electrical activity could be detected. The lateral wall tissues closer to the tricuspid valve were activated after 158 ms.
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mechanism of this observation is likely related to the
formation of a split atrial depolarization wavefront around
the catheter as a result of the lesion. The recording of
double potentials around an area of conduction block has
been previously described by Feld and Shahandeh-Rad (4).
Because these recordings are made from adjacent electrodes,
the destruction of the tissue underneath and between these
electrodes results in marked diminution of the recorded
electrical activity. Further confirmation of tissue destruction
is noted by the significant increase in the pacing threshold.
The ability to retrieve discrete localized recordings from
multiple electrodes provides atrial mapping capability and
allows for safeguarding of the His bundle.
Rhythm outcome. After 75% of the ablation procedures,
no arrhythmia was inducible. The most common arrhyth-
mia induced during the ablation procedures was sustained
atrial flutter, which was present after 42% of the individual
linear lesions and at the conclusion of 3/12 ablation proce-
dures. At baseline, these three hearts exhibited sinus
rhythm, sustained Afib and sustained atrial flutter, respec-
tively.
Atrial flutter circuits were created and terminated by
linear lesion generation. In four dogs, the generation of a
linear lesion in the LA resulted in the inducibility of
sustained atrial flutter that was not inducible preablation. In
three of these four dogs, atrial flutter was noninducible after
creating a single additional linear lesion (1 RAI, 2 LAV). In
an additional dog, sustained atrial flutter was inducible at
baseline, but only sinus rhythm was recorded after creating
a LAH lesion. In this study, Afib was never a consequence
of creating a linear lesion. In fact, in one dog with inducible
sustained Afib at baseline, the creation of linear lesions
eliminated the Afib. Additional studies are needed to show
that this technology and lesion set will be effective in
ablating Afib in a chronic model before evaluating its
efficacy in humans.
Atrial fibrillation ablation in humans. Recently several
reports were presented supporting the notion that chronic
Afib can be terminated in humans (5–7). Perhaps the most
important conclusion to be drawn from these studies is that,
despite the technological limitations and the uncertainty of
the character of the lesions that were created, the investi-
gators were still able to terminate Afib. Clearly, as we have
learned from Cox et al., to achieve a high degree of success
in most patients with chronic Afib, a careful Maze-type
procedure may be necessary. A procedure that requires a
thoracotomy may not allow for repeat surgery if the Afib
recurs. Thus, an extensive and meticulous complete Maze
procedure is required in every surgical patient to ensure the
desired outcome. If catheter-based ablation can be safely
developed, it would allow for extensive investigation into
the mechanisms of Afib in humans.
Conclusions. In this study, we wished to define the feasi-
bility of linear lesion generation in dogs and to describe the
basic characteristics of a catheter system that will have the
potential to ablate Afib by efficiently creating linear contig-
uous atrial lesions. Our present hypothesis is that successful
ablation of Afib will require a system that is easy to
manipulate, can conform to various atrial sizes and shapes
and can create effective contact by maintaining firm and
uniform catheter–tissue pressure. Firm contact with the
atrial tissue during RF energy application increases the
likelihood of transmural, contiguous lesion formation.
Although the results from animal studies may not be fully
extrapolated to the human heart, this catheter technology
shows great promise in creating the type of lesions that will
likely be necessary to ablate Afib in humans. The data
obtained with regard to linear lesion contiguity and trans-
murality, local electrogram changes and pacing thresholds
reflect the results obtained from this specific catheter design
and cannot be extrapolated to other designs.
The loop catheter system is capable of creating long linear
lesions (12 to 16 cm) at predefined anatomic locations. The
deployment of the catheter requires minimal radiation
exposure. It caused no perforations or valvular injuries.
However, the catheter could tear the septum if it is placed
transseptally, the sheath is retracted into the RA and the
catheter is deflected while still traversing the septal hole. In
addition, if it is deployed across the mitral ring it may
interfere with valvular closure. Once the catheter is posi-
tioned, no further movements are needed until the comple-
tion of the linear lesion. The methods described in this
Table 5. Rhythm Outcomes
Baseline RA Loop RAI LAH 1st LAV 2nd LAV End
Sinus 5 10 3 3 1 — 9*
NS Fltr 3 — — — — 1 —
S Fltr 2 2 1 4 4 2 3*
NS Afib — — — — — — —
S Afib 2 — — — — — —
*p is not significant comparing baseline versus after the completion of all the lesions. Five seconds of burst pacing was applied
before creating any lesions and after each lesion. The table summarizes the rhythm status in 12 dogs at baseline before any lesions
were created, after creating each individual linear lesion and at the end of all lesion generation.
Afib 5 atrial fibrillation; Baseline 5 before any lesions were made; End 5 after all lesions were created; Fltr 5 atrial flutter;
LAH 5 circular horizontal left atrial lesion; LAV 5 one of two vertical left atrial lesions; NS 5 nonsustained (30 to 180 s);
RAI 5 right atrial isthmus lesion; RA Loop 5 right atrial circular lesion; S 5 sustained (.180 s).
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report provide the operator with multiple means of assessing
the quality of lesion formation. Ideal lesions are likely to
result when thermistors are used to maintain the tempera-
ture at 70°C, the local electrical activity amplitude is reduced
by 50% of its baseline value, splitting of the atrial depolar-
ization is noted and the atrial pacing threshold increases.
Atrial fibrillation was never a consequence of creating a
linear lesion in any of the 12 dogs that were tested for
inducible arrhythmia, but sustained atrial flutter was induc-
ible after the completion of all the lesions in three dogs
(25%).
Limitations. In these acute studies, the dogs were not
anticoagulated. Long-term complications such as pericardi-
tis or pericardial effusion could not be assessed, but there
were no atrial perforations in any of the procedures. The
potential correlation between the microscopic analysis of the
tissues for lesion contiguity and transmurality and the
inducibility of atrial flutter postablation was not assessed.
However, the high density epicardial maps and the appear-
ance of split potentials postablation both indicate the
formation of conduction block across lesions. In those dogs
with inducible atrial flutter, such flutter is likely a result of
a reentry around an incomplete lesion. These ablation
procedures were carried out in dogs with normal hearts.
Further investigation of this technology and technique
needs to be performed in a chronic model of Afib to assess
its curative efficacy.
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